Gastric Cancer Market Dynamics 2026: Future Outlook and Key Insights

Uncover key drivers, emerging technologies, and competitive movements shaping the gastric cancer market from 2026–2035 with trusted insights from The Business Research Company

Starting from its 2026 valuation, what market size is the Gastric Cancer Market expected to reach by 2030?

The gastric cancer market size has experienced rapid growth in recent years. It is set to expand from $3.64 billion in 2025 to $4.19 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 15.2%. The historical increase can be ascribed to a significant prevalence of helicobacter pylori infection, smoking, and dietary risk factors, alongside the broadening use of chemotherapy, the development of hospital-based oncology care, and progress in surgical oncology.

The gastric cancer market is projected for significant expansion in the coming years. By 2030, this market is anticipated to reach $7.29 billion, demonstrating a compound annual growth rate (CAGR) of 14.8%. This expansion during the forecast period can be ascribed to progress in immuno-oncology, the development of precision diagnostics, the proliferation of cancer screening initiatives, an expanding aging demographic, and the creation of innovative targeted medications. Key trends anticipated for this period involve the increasing uptake of targeted and immunotherapies, a heightened emphasis on early diagnosis and screening, the broadening of personalized cancer treatment strategies, greater application of combination therapy protocols, and enhanced multidisciplinary cancer care frameworks.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20797&type=smp

What Drivers Are Driving Adoption Within The Gastric Cancer Market?

The growth of the gastric cancer market is expected to be propelled by increasing obesity rates. Obesity is a medical condition marked by excessive body fat accumulation, commonly defined by a body mass index (BMI) of 30 or higher, which can lead to various health issues. The rise in obesity rates is attributed to factors like poor diet, lack of physical activity, sedentary lifestyles, environmental influences, and genetic predispositions. Excess body fat, particularly visceral fat around the abdomen, is associated with a higher risk of developing gastric cancer, as obesity triggers chronic inflammation and metabolic disturbances, both linked to cancer development, thereby contributing to a rise in the demand for gastric cancer treatment. For instance, in March 2024, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, reported that one in eight people worldwide now live with obesity, exceeding 1 billion individuals. Consequently, the rising obesity rates are driving the gastric cancer market.

What Segments Are Included Within The Gastric Cancer Market?

The gastric cancer market covered in this report is segmented –

1) By Type: Adenocarcinoma, Lymphoma, Gastrointestinal Stromal Tumor, Carcinoid Tumor, Other Types

2) By Diagnosis: Endoscopy, Biopsy, Imaging Tests, Exploratory Surgery, Other Diagnosis

3) By Treatment: Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, Palliative Care, Other Treatments

4) By Distribution Channel: Hospital Pharmacies, Specialty And Retail Pharmacies, Other Distribution Channels

Subsegments:

1) By Adenocarcinoma: Intestinal Type Adenocarcinoma, Diffuse Type Adenocarcinoma, Mixed Type Adenocarcinoma

2) By Lymphoma: Primary Gastric Lymphoma, Secondary Gastric Lymphoma

3) By Gastrointestinal Stromal Tumor (GIST): Primary GIST, Metastatic GIST

4) By Carcinoid Tumor: Gastric Carcinoid Type 1, Gastric Carcinoid Type 2, Gastric Carcinoid Type 3

5) By Other Types: Small Cell Carcinoma, Squamous Cell Carcinoma, Mixed Tumors

Which Market Trends Are Opening Growth Opportunities In The Gastric Cancer Market?

Leading companies in the gastric cancer market are dedicating efforts to developing advanced technological solutions, such as companion diagnostic assays, to facilitate personalized treatment. A companion diagnostic assay is a diagnostic tool employed to identify patients most likely to benefit from a specific therapeutic intervention based on the presence of particular biomarkers. For instance, in October 2024, F. Hoffmann-La Roche Ltd., a Switzerland-based pharmaceutical entity, announced that the U.S. Food and Drug Administration (FDA) had approved its VENTANA CLDN18 (43-14A) RxDx Assay. This represents the inaugural immunohistochemistry (IHC) companion diagnostic for assessing CLDN18 protein expression in adenocarcinoma of the stomach and gastroesophageal junction (GEJ). This assay is designed to identify patients eligible for targeted treatment with VYLOY (zolbetuximab) by measuring CLDN18 protein variants, primarily CLDN18. 2. By utilizing the OptiView DAB IHC Detection Kit on the BenchMark ULTRA instrument, this test significantly advances personalized healthcare and expands the treatment options available for gastric and GEJ adenocarcinoma.

Who Are The Top-Performing Companies In The Gastric Cancer Market In Recent Years?

Major companies operating in the gastric cancer market are F. Hoffmann La Roche Ltd., Merck And Co. Inc., AbbVie Inc., Sanofi S.A., Bristol Myers Squibb Company, Novartis AG, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Ipsen Biopharmaceuticals Inc., Ono Pharmaceutical Co. Ltd., Taiho Oncology Inc., Taiho Pharmaceuticals Co. Ltd., Boehringer Ingelheim, Biocon Limited, Jiangsu Hengrui Medicine Co Ltd, BeiGene Ltd

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/gastric-cancer-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Gastric Cancer Market?

North America was the largest region in the gastric cancer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastric cancer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Gastric Cancer Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20797&type=smp

Browse Through More Reports Similar to the Global Gastric Cancer Market 2026, By The Business Research Company

Esophageal Cancer Market Report 2026

https://www.thebusinessresearchcompany.com/report/esophageal-cancer-global-market-report

Gastric Cancer Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/gastric-cancer-drugs-global-market-report

Gastric Ulcers Market Report 2026

https://www.thebusinessresearchcompany.com/report/gastric-ulcers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795